Eventide Asset Management’s Medtronic MDT Stock Holding History

Eventide Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1M	Buy	138,227 +24,493	+22%	+$1.98M	0.15%	148
2026 Q1	$9.79M	Buy	113,734 +1,470	+1%	+$141K	0.16%	141
2025 Q4	$10.8M	Buy	112,264 +58,023	+107%	+$5.64M	0.17%	138
2025 Q3	$5.13M	Buy	54,241 +26,142	+93%	+$2.4M	0.08%	144
2025 Q2	$2.51M	Buy	+28,099	New	+$2.38M	0.04%	159

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Eventide Asset Management's MDT Position: Q2 2026 in Review

Eventide Asset Management increased its Medtronic (MDT) stake by 22% in Q2 2026, buying an estimated $1.98M and bringing the position to 138,227 shares worth $11.1M. The position accounts for 0.15% of the portfolio, ranked #148.

Eventide Asset Management first reported a position in MDT in Q2 2025 and has held it in 5 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Eventide Asset Management held 138,227 shares of Medtronic worth $11.1M as of Q2 2026.
Eventide Asset Management bought 24,493 Medtronic shares in Q2 2026, an estimated $1.98M.
Medtronic made up 0.15% of Eventide Asset Management's portfolio in Q2 2026, its #148 holding.
Eventide Asset Management first reported a position in Medtronic in Q2 2025 and has held it in 5 quarters since.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.